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During mammalian cerebral cortex development, the G1-phase of the cell cycle is known to 
lengthen, but it has been unclear which neural stem and progenitor cells are affected. In this 
paper, we develop a novel approach to determine cell-cycle parameters in specific classes of 
neural stem and progenitor cells, identified by molecular markers rather than location. We found 
that G1 lengthening was associated with the transition from stem cell-like apical progenitors 
to fate-restricted basal (intermediate) progenitors. Unexpectedly, expanding apical and basal 
progenitors exhibit a substantially longer S-phase than apical and basal progenitors committed 
to  neuron  production.  Comparative  genome-wide  gene  expression  analysis  of  expanding 
versus committed progenitor cells revealed changes in key factors of cell-cycle regulation, DNA 
replication and repair and chromatin remodelling. Our findings suggest that expanding neural 
stem and progenitor cells invest more time during S-phase into quality control of replicated 
DNA than those committed to neuron production. 
1 Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307 Dresden, Germany. 2 Center for Regenerative Therapies, 
Technische Universität Dresden, Tatzberg 47/49, 01307 Dresden, Germany. Correspondence and requests for materials should be addressed to W.B.H. 
(email: huttner@mpi-cbg.de). 
Neural stem and progenitor cells shorten S-phase 
on commitment to neuron production
Yoko Arai1, Jeremy N. Pulvers1, Christiane Haffner1, Britta Schilling1, Ina Nüsslein1, Federico Calegari2  
& Wieland B. Huttner1
ARTICLE
 NATURE COmmUNICATIONS | 2:154 | DOI: 10.1038/ncomms1155 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.ARTICLE

NATURE COmmUNICATIONS | DOI: 10.1038/ncomms1155
NATURE COmmUNICATIONS | 2:154 | DOI: 10.1038/ncomms1155 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
D
uring development of the mammalian cerebral cortex, neu-
rons are generated from two principal classes of neural pro-
genitor cells (NPCs). One class consists of somatic stem cell-
like neuroepithelial cells and radial glial cells, collectively referred 
to as apical progenitors (APs), which exhibit apical–basal polarity, 
undergo mitosis at the ventricular (apical) surface, and the cell bod-
ies of which constitute the ventricular zone (VZ)1–4. The second class 
consists  of  NPCs  that  originate  from  apical  mitoses,  translocate 
their cell bodies through the VZ in the basal direction, delaminate   
from  the  ventricular  surface  to  form  the  subventricular  zone 
(SVZ), downregulate apical–basal polarity (at least in rodents) and 
undergo mitosis in the basal VZ or SVZ5–9; these NPCs are called 
basal progenitors (BPs)2 or intermediate progenitor cells4. Regarding 
the balance between NPCs and neurons, there are three principal 
types of AP and BP divisions: self-expanding symmetric prolifera-
tive, self-renewing asymmetric BP- or neuron-generating, and self-
  consuming neurogenic3,10. The spatial organization of APs and BPs 
in M-phase is one key determinant of the type of NPC division2,3,11.
Another key determinant is of a temporal nature. Specifically, 
concomitant  with  progression  of  neurogenesis,  cell-cycle  length 
of cortical NPCs in the VZ is known to increase12–14, and there are 
intriguing links between NPC cell-cycle length and neuron out-
put15–17.  NPC  cell-cycle  lengthening  pertains  specifically  to  the   
G1-phase12,14,15  and  can  be  a  cause  (rather  than  a  consequence)   
of neurogenesis16–18. Conversely, reducing cell-cycle length, specifi-
cally G1, of NPCs in the cerebral cortex has recently been found to 
promote their expansion, with a transient delay in neurogenesis19,20.
However, taking into account the coexistence of APs and new-
born BPs in the VZ with the onset of neurogenesis, it is unclear 
whether  cell-cycle  lengthening  of  NPCs  in  the  VZ,  concomi-
tant with the progression of neurogenesis, reflects the following: 
cell-cycle  lengthening  in  an  AP  sub-population,  as  previously 
assumed14; an increasing contribution, in the VZ, of newborn BPs, if 
these were to have a longer cell cycle than APs; or both. The second   
possibility is particularly relevant for consideration because, with 
progression of neurogenesis, an increasing proportion of APs switch 
to generate BPs6.
In  addition,  determination  of  cell-cycle  parameters  of  BPs  is 
important per se. BPs, and SVZ progenitor cells in general, have 
been  implicated  in  cortical  expansion  during  evolution21,22.  In 
rodents, BPs have been shown to undergo symmetric proliferative 
divisions, which result in their expansion, and symmetric neuro-
genic divisions, which result in their consumption8–10,21,23. It is thus 
of interest to determine whether proliferative and neurogenic BPs 
differ in their cell-cycle parameters.
In the present study, we determined the cell-cycle parameters of 
BPs and compared them with APs, using cumulative labelling with 
thymidine analogues24. Compared with other approaches such as 
determining the time between two NPC divisions by live imaging in 
organotypic slice culture (for example, see ref. 20), cumulative label-
ling has the advantages of being carried out in vivo and providing 
information on individual cell-cycle phases. However, a prerequisite 
for this approach is a reliable means of identifying BPs. Determin-
ing the accumulation, in the SVZ, of interphase nuclei containing 
an S-phase label25, as was previously considered appropriate for APs 
by analysing interphase nuclei in the VZ12, may not be appropriate 
because, in the SVZ, BPs are intermingled with postmitotic neurons 
that inherit S-phase label from BPs, and a substantial proportion of 
BP nuclei in interphase, notably those of newborn BPs in G1, are 
located in the VZ, intermingled with AP interphase nuclei. Conse-
quently, we have chosen to identify BP interphase nuclei and, for com-
parison, AP interphase nuclei, using molecular markers rather than 
SVZ versus VZ location. In the embryonic mouse cerebral cortex, 
virtually all apical mitoses, which by definition are APs11,26, are posi-
tive for Pax6, a transcription factor specifically expressed by neu-
roepithelial and radial glial cells and involved in their proliferation   
and neurogenesis27–29. Conversely, virtually all mitoses in the basal 
VZ and SVZ (collectively referred to as basal mitoses) are positive 
for the transcription factor Tbr2, a known marker of BPs30,31 that 
controls the production of pyramidal neurons32,33.
Given the availability of these molecular markers, in this study, 
we  have  developed  a  novel  approach  of  determining  cell-cycle 
parameters of APs and BPs by cumulative labelling with thymidine 
analogues. We find that BPs have a substantially longer G1-phase 
than APs, and that the previously observed G1 lengthening of neu-
rogenic NPCs in the VZ14 actually reflects the increasing contribu-
tion of BPs. Moreover, we used the antiproliferative gene Tis2134,35, 
specifically  Tis21-GFP  knock-in  mouse  embryos6,  to  distinguish 
neuronally committed from self-expanding APs and BPs, and find 
that the latter exhibit a substantially longer S-phase than the former, 
suggesting a greater time investment into quality control of repli-
cated DNA in expanding NPCs.
Results
Identification of APs and BPs on the basis of molecular markers. 
Our study investigates NPCs in the mouse �14.5 cerebral cortex. investigates NPCs in the mouse �14.5 cerebral cortex.  NPCs in the mouse �14.5 cerebral cortex. 
We  first  confirmed  the  previous  observations30,31  that  Pax6  and 
Tbr223,27,28,30,31,36  are  expressed  in  virtually  all  apical  and  basal 
mitoses,  respectively  (Supplementary  Fig.  S1).  As  described  in 
Supplementary Note S1, we identified AP or BP nuclei irrespective 
of their localization in the VZ or SVZ and defined Pax6-positive/
Tbr2-negative  (Pax6 + /Tbr2 − )  interphase  nuclei  as  AP  nuclei, 
thereby excluding interphase nuclei of newborn BPs from the AP 
population. Similarly, we used the neuronal marker Tbr1 (ref. 30) 
to define Tbr2-positive/Tbr1-negative (Tbr2 + /Tbr1 − ) interphase 
nuclei as BP nuclei, thereby excluding nuclei of neurons from the 
BP population.
To determine the extent of intermingling of AP and BP interphase 
nuclei in the VZ and SVZ, and the proportion of APs committed to 
the neurogenic lineage, we performed triple immunofluorescence 
for Pax6, Tbr2 and Tis21-GFP, which is specifically expressed in the 
sub-population of APs that generate neurons or neurogenic BPs6,9 
(Fig. 1a). With regard to APs, virtually all interphase nuclei in the 
VZ were Pax6 + , as reported previously27,30,31. Counter immunofluo-
rescence for Tbr2 revealed that ≈30% of Pax6 +  interphase nuclei in 
the VZ were Tbr2 +  (Fig. 1b), indicating that APs contributed ≈70% 
and newborn BPs ≈30% to VZ interphase nuclei (Supplementary 
Fig. S2).
In the SVZ, 26% of interphase nuclei were Pax6 + , although most 
of these nuclei exhibited a lower level of Pax6 immunoreactivity 
compared with VZ nuclei. The overwhelming majority (≈85%) of 
Pax6 +  interphase nuclei in the SVZ were also Tbr2 +  and hence 
belonged to newborn BPs, whereas ≈15% of the Pax6 +  SVZ nuclei 
were Tbr2 −  (Fig. 1b) and presumably belonged to APs the interki-
netic nuclear migration of which extended into the SVZ. Analysis of 
Tbr2 − /Pax6 +  nuclei in the VZ and SVZ for Tis21-GFP expression 
showed that ≈40% of APs had switched to generating neurons or 
neurogenic BPs (Fig. 1c; Supplementary Fig. S2).
In contrast to the partial overlap between the populations of 
Pax6 +  and Tbr2 +  nuclei, we observed very little (if any) overlap 
between the Pax6 +  and Tbr1 +  nuclei populations (Fig. 1d). This 
indicated that Pax6 expression, although extending into a portion of 
the BP population, did not significantly extend into the population 
of newborn neurons. Consistent with this conclusion, we observed 
very little (if any) immunostaining for βIII-tubulin (Tuj1), a marker 
of newborn neurons, in the VZ (Fig. 1e).
With regard to BPs, in addition to the ≈30% fraction of inter-
phase nuclei in the VZ, the vast majority (≈90%) of interphase nuclei 
in the SVZ were Tbr2 +  (Fig. 1f). Counter immunofluorescence for 
Tbr1 revealed that  < 5% of the Tbr2 +  interphase nuclei in the VZ 
were Tbr1 +  (Fig. 1g), indicating that BPs contributed  > 95% to the 
Tbr2 +  interphase nuclei in the VZ. In the SVZ, ≈40% of Tbr2 +   ARTICLE     
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nuclei were also Tbr1 +  and hence belonged to newborn neurons, 
whereas ≈60% of the Tbr2 +  interphase nuclei were Tbr1 −  (Fig. 
1g) and hence BPs. Analysis of the Tbr1 − /Tbr2 +  nuclei in the VZ   
and SVZ for Tis21-GFP expression showed that  > 80% of BPs were 
neurogenic (Fig. 1h). A summary of the population analysis in the 
VZ and SVZ is illustrated in Supplementary Figure S2.
BPs have a longer cell cycle than APs. We next used the above 
information to determine the cell-cycle parameters of Tis21-GFP-
negative (Tis21-GFP − ) and -positive (Tis21-GFP + ) APs and BPs, 
using cumulative labelling with 5-ethynyl-2-deoxyuridine (�dU). 
As described in Supplementary Note S2, it was appropriate to use 
�dU  instead  of  5-bromo-2-deoxyuridine  (BrdU;  Supplementary 
Figs S3 and S4). Cumulative �dU labelling was performed in con-
junction  with  triple  immunostaining  for  either  Pax6,  Tbr2  plus 
Tis21-GFP  (Fig.  2a,b)  or  Tbr2,  Tbr1  plus  Tis21-GFP  (Fig.  2c,d) 
to  determine  the  cell-cycle  parameters  for  APs  (Tbr2 − /Pax6 + )   
and BPs (Tbr1 − /Tbr2 + ), respectively, and to distinguish between 
proliferative  (Tis21-GFP − )  and  neurogenic  (Tis21-GFP + )  NPC 
sub-populations. As shown in Figure 2e and summarized in Table 1,   
this revealed that the length of G2 + M + G1 (TC–TS), as indicated 
by the time point at which the �dU labelling index reached the pla-
teau, was longer for the total population of BPs (23.3 h) than APs 
(14.1 h). In contrast, the proportion of the cell cycle comprising S-
phase, as indicated by the intercept of the cumulative �dU labelling 
curve with the y axis, was smaller for BPs (12%) than for APs (26%). 
The growth fraction was nearly 100% for both, APs and BPs. Cal-
culation of the length of S-phase (TS) and the total cell cycle (TC)24 
yielded values of 5.0 and 19.1 h for APs and 3.2 and 26.5 h for BPs. 
The present TC data determined by cumulative �dU labelling are 
very similar to those determined by live imaging in organotypic 
slice culture7,20.
Proliferative NPCs have a longer S-phase than neurogenic NPCs. 
We next analysed the cell-cycle parameters separately for Tis21-
GFP −  APs and BPs, that is, those destined to undergo proliferative 
divisions6, and Tis21-GFP +  APs and BPs, that is, those destined   
to undergo BP-genic (APs) and neurogenic (APs, BPs) divisions6,9 
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Figure 1 | Classification of proliferative and neurogenic APs and BPs on the basis of differential marker expression. (a) Pax6 (red), Tbr2 (blue), Tis21-GFP 
(green) and DAPI (white) staining. Red arrowheads, Pax6 + /Tbr2 − /Tis21-GFP −  nuclei (APs); yellow arrowheads, Pax6 + /Tbr2 + /Tis21-GFP +  nuclei (BPs); 
blue arrowheads, Pax6 − /Tbr2 + /Tis21-GFP +  nucleus (BP). Scale bar, 50 µm. (b) Quantification of Tbr2 + /Pax6 +  (blue–red) and Tbr2 − /Pax6 +  (red) 
nuclei in VZ, SVZ and VZ + SVZ, each expressed as a percentage of total Pax6 +  nuclei. (c) Quantification of the percentage of Tis21-GFP +  (green) and 
Tis21-GFP −  (white) Tbr2 − /Pax6 +  nuclei in VZ + SVZ. ( d, e) Pax6 (red), Tbr1 (d) or Tuj1 (e) (green) and DAPI (white) staining. Scale bar, 50 µm. (f) Tbr2 
(red), Tbr1 (blue), Tis21-GFP (green) and DAPI (white) staining. Red arrowheads, Tbr2 + /Tbr1 − /Tis21-GFP +  nucleus (BP); yellow arrowheads, Tbr2 + /
Tbr1 + /Tis21-GFP +  nucleus (neuron); blue arrowheads, Tbr2 − /Tbr1 + /Tis21-GFP +  nucleus (neuron). Scale bar, 50 µm. (g) Quantification of Tbr1 + /Tbr2 +  
(blue–red) and Tbr1 − /Tbr2 +  (red) nuclei in VZ, SVZ and VZ + SVZ, each expressed as a percentage of total Tbr2 +  nuclei. (h) Quantification of the 
percentage of Tis21-GFP +  (green) and Tis21-GFP −  (white) Tbr1 − /Tbr2 +  nuclei in VZ + SVZ. (a, d, e, f) White lines at margins, VZ and SVZ boundaries.  
(b, c, g, h) Data are the mean of three 225-µm-wide fields, each from a different brain and litter; error bars indicate s.e.m. Images in (a, d, f) and data in  
(b, c, g, h) are from embryos subjected to cumulative EdU labelling for 5 h (a, d), 1 h (f) and 5, 9 and 12 h (b, c, g, h; compare Supplementary Fig. S4).ARTICLE
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(Fig. 2f, Table 1). TC–TS was nearly identical for proliferative (14.1 h) 
and BP-genic/neurogenic (14.0 h) APs, and the same was the case for 
the longer TC–TS of proliferative (23.0 h) versus neurogenic (23.4 h) 
BPs. However, interestingly, the TS value of BP-genic/neurogenic 
APs and neurogenic BPs was significantly shorter (1.8 and 2.8 h, 
respectively) than that of proliferative APs and BPs (8.3 and 6.4 h, 
respectively). This resulted in a shorter TC of BP-genic/neurogenic 
APs (15.8 h) than of proliferative APs (22.4 h), and of neurogenic 
BPs (26.2 h) than of proliferative BPs (29.4 h). Given that the Tis21-
GFP +  sub-population is greater for BPs ( > 80%, Fig. 1h) than for 
APs  (≈40%,  Fig.  1c),  the  shorter  S-phase  duration  of  BP-genic/
neurogenic compared with proliferative NPCs (Fig. 2f) contributed 
to the observation (Fig. 2e) that S-phase comprised a smaller pro-
portion of the TC of BPs than of APs.
We  sought  to  corroborate  the  difference  between  APs  and 
BPs  with  regard  to  the  S-phase  proportion  relative  to  the 
total  cell  cycle  by  determining  the  proportion  of  NPCs  in  S-
phase  using  an  independent  method,  that  is,  proliferating 
cell  nuclear  antigen  (PCNA)  immunostaining.  Cell  nuclei  in   
S-phase typically exhibit a punctate pattern of PCNA immunore-
activity, which reflects sites of DNA replication, whereas nuclei in 
G1 and G2 show diffuse PCNA immunoreactivity (Fig. 3a–d)37,38. 
Determination of the percentage of Pax6 +  (Fig. 3a) and Tbr2 +   
(Fig. 3b) nuclei in S-phase by PCNA immunostaining, together with 
correction for the contribution of neurons to the Tbr2 +  nuclei and 
of BPs to the Pax6 +  nuclei (Fig. 1b,g) as described in the Methods, 
allowed us to calculate the percentage of APs and BPs in S-phase 
(30 ± 4 and 14 ± 4%, respectively; Fig. 3e). Very similar data to that 
shown in Figure 3e (�dU-labelled samples) were obtained when 
embryos not exposed to �dU were analysed (APs 26 ± 6% (n = 3); 
BPs 12 –14% (n = 2)). These data compare well with the mean pro-
portion of NPCs in S-phase as determined from the intercept of the 
cumulative �dU-labelling curves with the y axis (Fig. 2e).
Longer cell cycle of BPs than of APs is due to G1 lengthening. We 
combined �dU labelling with immunostaining for phosphohistone 
H3 (PH3), an indicator of late G2- and M-phase39, to investigate the 
duration of G2 and M in the various NPC populations. PH3 +  cells, 
the mitotic state (as opposed to late G2) of which was confirmed 
by 4,6-diamidino-2-phenylindole (DAPI) staining, were classified 
as either APs or BPs on the basis of their location at the ventricu-
lar surface or in the basal VZ/SVZ, respectively (Fig. 4a,b), and as 
undergoing proliferative or neurogenic division on the basis of the 
absence or presence, respectively, of Tis21-GFP (Fig. 4c,d).
Analysis of the appearance of �dU label in mitotic figures (mitotic 
�dU labelling index) revealed a very similar time course for the four 
NPC populations (Fig. 4e), with almost all mitotic NPCs becom-
ing �dU +  2–3 h after �dU administration, indicating an average 
G2-length (TG2) of  < 2 h (~1.6 h). With regard to M-phase, we first 
determined the percentages of total Tis21-GFP −  and Tis21-GFP +   
APs and BPs, identified as in Figure 1, that were in M-phase by DAPI 
staining and PH3 immunofluorescence as in Figure 4a–d, and then 
calculated the length of M-phase (TM) in the four NPC populations 
from the respective TC. This revealed that TM was longer in APs than 
in BPs, being longest in Tis21-GFP −  APs (Table 1).
The determination of TC, TS, TG2 and TM allowed us to calculate 
the length of G1 (TG1). TG1 was found to be almost twice as long 
for BPs than for APs, and for either type of NPC was not signifi-
cantly  different  for  the  proliferative  and  BP-genic/neurogenic   
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Figure 2 | Cumulative EdU labelling of proliferative and neurogenic APs 
and BPs. (a, b) Pax6 (magenta), Tbr2 (blue), Tis21-GFP (green) and EdU 
(white) staining after cumulative EdU labelling for 9 h. Individual AP nuclei 
indicated by arrows/arrowheads in (a) are shown at higher magnification 
in (b) (asterisks); white arrowheads, Pax6 + /Tbr2 − /Tis21-GFP − /EdU −  
nucleus; white arrows, Pax6 + /Tbr2 − /Tis21-GFP − /EdU +  nucleus; yellow 
arrowheads, Pax6 + /Tbr2 − /Tis21-GFP + /EdU −  nucleus; yellow arrows, 
Pax6 + /Tbr2 − /Tis21-GFP + /EdU +  nucleus. VZ and SVZ are indicated on 
the left. Scale bars, 50 µm (a) and 10 µm (b). (c, d) Tbr2 (magenta), Tbr1 
(blue), Tis21-GFP (green) and EdU (white) staining after cumulative EdU 
labelling for 9 h. Individual BP nuclei indicated by arrows/arrowheads in 
(c) are shown at higher magnification in (d) (asterisks); white arrowheads, 
Tbr2 + /Tbr1 − /Tis21-GFP − /EdU −  nucleus; white arrows, Tbr2 + /Tbr1 − /
Tis21-GFP − /EdU +  nucleus; yellow arrowheads, Tbr2 + /Tbr1 − /Tis21-
GFP + /EdU −  nucleus; yellow arrows, Tbr2 + /Tbr1 − /Tis21-GFP + /EdU +  
nucleus. VZ and SVZ are indicated on the left. Scale bars, 50 µm (c) and 
10 µm (d). (e, f) Proportion of EdU-labelled NPC nuclei (EdU labelling 
index) after cumulative EdU labelling for 0.5, 1, 2, 3, 5, 9, 12, 18, 24 and 
29 h. The EdU labelling index was separately determined for the various 
AP (Pax6/Tbr2/GFP/EdU staining as in (a)) and BP (Tbr2/Tbr1/GFP/EdU 
staining as in (c)) populations, as follows: total APs (e, Tbr2 − /Pax6 + , blue 
circles), total BPs (e, Tbr1 − /Tbr2 + , red squares), proliferative APs  
(f, Tbr2 − /Pax6 + /Tis21-GFP − , blue diamonds), BP-genic/neurogenic  
APs (f, Tbr2 − /Pax6 + /Tis21-GFP + , purple squares), proliferative BPs  
(f, Tbr1 − /Tbr2 + /Tis21-GFP − , red triangles) and neurogenic BPs  
(f, Tbr1 − /Tbr2 + /Tis21-GFP + , green crosses). Data are the mean of three 
225-µm-wide fields (except for the 1-, 9- and 29-h time points, which are 
from five, two and one field(s), respectively), each from a different brain 
and litter; error bars indicate s.e.m. or the range of the two individual 
values. Dashed lines and colour-coded arrowheads indicate the growth 
fraction; colour-coded arrows indicate the time point at which the labelling 
index reaches a plateau (TC–TS).ARTICLE     
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sub-populations (APs, 11.4 and 11.7 h, respectively; BPs, 20.9 and 
21.3 h, respectively; Fig. 4f, Table 1).
Higher DNA synthesis rate in Tis21-GFP +  than in Tis21-GFP −   
NPCs. To investigate possible mechanisms underlying the S-phase 
shortening in Tis21-GFP +  compared with Tis21-GFP −  NPCs, we 
performed  �dU  pulse-labelling  for  30 min  in  vivo  and  analysed 
dissociated single Tis21-GFP −  and Tis21-GFP +  NPCs, separated 
by fluorescence-activated cell sorting (FACS), by flow cytometry. 
Comparison of the overtly �dU-incorporating Tis21-GFP −  (Fig. 
5a, dashed line) and Tis21-GFP +  (Fig. 5b, dashed line) NPC popu-
lations revealed a 20% increase in the rate of �dU incorporation in 
Tis21-GFP +  cells (Fig. 5c). This increase was corroborated when 
only the overtly �dU-incorporating NPCs in S-phase, as defined by 
DNA content (Fig. 5d,e), were quantified, and observed for cells in 
early and late S-phase (Fig. 5f; Fig. 5g,h for Tis21-GFP − ; Fig. 5i,j for 
Tis21-GFP + ). Thus, Tis21-GFP +  NPCs exhibited a higher rate of 
DNA synthesis than Tis21-GFP −  NPCs, although the magnitude 
of this increase (1.2-fold change) was clearly less than that of the 
reduction  in  S-phase  duration  (3.3-fold  change)  in  Tis21-GFP +   
compared with Tis21-GFP −  NPCs (Fig. 4f, Table 1, see Supplemen-
tary Fig. S2 for proportions of NPC sub-populations).
Increased PCNA level in short S-phase duration nuclei. We also 
analysed the intensity and sub-nuclear pattern of PCNA immuno-
reactivity in NPC populations with different S-phase durations. As 
high-resolution PCNA immunostaining was not compatible with 
detecting  Tis21-GFP  (see  Methods),  we  combined  it  with  Tbr2 
immunofluorescence, reasoning that a Tbr2 +  S-phase nucleus can 
be attributed to a BP and a Tbr2 −  S-phase nucleus to an AP. Given 
that S-phase in the total BP population is substantially shorter than 
in the total AP population (3.2 versus 5.0 h, Table 1), which reflects 
the fact that the BP population contains twice as many Tis21-GFP +   
NPCs as the AP population (80 versus 40%, Fig. 1c,h, Supplemen-
tary Fig. S2), comparison of PCNA immunostaining between Tbr2 +   
and Tbr2 −  nuclei may reveal differences in the DNA replication 
machinery that are related to alterations in S-phase duration.
In  accordance  with  previous  observations  with  non-neural 
cells40,41, we considered the following: AP and BP nuclei exhibiting 
diffuse PCNA immunoreactivity to be in G1 or G2 (see Fig. 3c,d); 
nuclei exhibiting numerous small PCNA puncta above the level of 
diffuse PCNA immunoreactivity to be in early S-phase (Fig. 6a); 
and nuclei exhibiting strong, occasionally clustered PCNA puncta 
well above the level of diffuse PCNA immunoreactivity to be in late 
S-phase (Fig. 6b). Quantification of the average PCNA immuno-
fluorescence of a nucleus showed that this value extended over a cer-
tain range for both early (Fig. 6c) and late (Fig. 6d) S-phase nuclei. 
Plotting  these  values  in  ascending  order  for  late  S-phase  nuclei 
revealed a significant difference between Tbr2 −  and Tbr2 +  nuclei 
(Fig. 6d), with the mean value of Tbr2 +  nuclei being 18% higher 
than that of Tbr2 −  nuclei (Fig. 6e), whereas no significant difference 
was observed between early S-phase Tbr2 −  and Tbr2 +  nuclei (Fig. 
6c,e). Thus, nuclei with, on average, a shorter S-phase (BPs) appear 
to maintain PCNA immunoreactivity at late S-phase at higher levels 
than nuclei with, on average, a longer S-phase (APs), although the 
magnitude of this increase (1.2-fold change) was less than that of 
the reduction in S-phase duration (1.6-fold change) in BPs relative 
to APs (Table 1, see Supplementary Fig. S2 for proportions of NPC 
sub-populations). Moreover, the s.d. of PCNA immunofluorescence 
between the pixels of a given nucleus was similar for Tbr2 −  and 
Tbr2 +  nuclei in early S-phase, but was significantly higher for Tbr2 +   
than for Tbr2 −  nuclei in late S-phase (Fig. 6f). This suggested that 
the variability of clustered PCNA immunoreactivity at late S-phase 
was greater in nuclei with, on average, a shorter S-phase (BPs) than 
nuclei with, on average, a longer S-phase (APs).
Candidate genes for reducing S-phase duration of NPCs. To gain 
further insight into the molecules possibly involved in these cell-
cycle alterations, notably the S-phase shortening in Tis21-GFP +   
compared with Tis21-GFP −  NPCs, we carried out a genome-wide 
analysis of changes in mRNA levels. For this purpose, living Tis21-
GFP −   and  Tis21-GFP +   NPCs  in  S-phase,  as  defined  by  DNA 
content, were isolated by FACS (Supplementary Fig. S5) and sub-
jected to microarray analysis. The FACS-based separation of Tis21-
GFP −  and Tis21-GFP +  NPCs was validated by analysis of mRNAs 
expected to be up- or down-regulated in these NPC populations 
(Table 2, see Supplementary Note S3).
Genome-wide  analysis  revealed  1,098  annotated  mRNAs,  the 
levels of which showed a statistically significant (P < 0.05) ≥1.2-fold 
change  in  Tis21-GFP +   S-phase  NPCs  as  compared  with  Tis21-
GFP − S-phase NPCs, with 410 mRNAs being upregulated and 688 
mRNAs  downregulated  in  Tis21-GFP +   cells.  Table  2  lists  those 
among the 1,098 genes the functions of which suggested that they 
may be involved in the observed cell-cycle phase alterations, nota-
bly the 3.3-fold reduction in S-phase duration (from 8.0 to 2.4 h,   
Table  1),  in  Tis21-GFP +   compared  with  Tis21-GFP −   NPCs. 
Indeed, alterations in mRNA levels were observed for genes involved 
in cell-cycle regulation and DNA replication and repair. Specifi-
cally, genes expected to be associated with a reduction in S-phase   
duration, such as the transcription factor E2f1 (refs 42, 43), the 
phosphatase Cdc25a (ref. 44), cyclin G2 (ref. 45) and topoisomerase 
II alpha46, showed upregulated mRNA levels in Tis21-GFP +  NPCs. 
Conversely, genes expected to be associated with an increase in S-phase   
duration,  such  as  the  repressor  Erf47,48  and  the  ubiquitin  ligase 
  complex subunit Fbxw7 (ref. 49), showed downregulated mRNA 
levels in Tis21-GFP +  NPCs.
Table 1 | Cell-cycle parameters of Tis21-GFP −  and Tis21-GFP +  APs and BPs in E14.5 mouse neocortex.
Cell-cycle phases (h) Growth fraction 
(% ± s.e.m.)
TC-TS TS TC TG2 TM TG1
APs (Pax6 + /Tbr2 − ) 14.1 5.0 19.1 1.6 0.9 11.6 98 ± 1
Tis21-GFP −  14.1 8.3 22.4 1.6 1.1 11.4 98 ± 1
Tis21-GFP +  14.0 1.8 15.8 1.6 0.7 11.7 99 ± 0.5
BPs (Tbr2 + /Tbr1 − ) 23.3 3.2 26.5 1.6 0.5 21.2 99 ± 1
Tis21-GFP −  23.0 6.4 29.4 1.6 0.5 20.9 99 ± 1
Tis21-GFP +  23.4 2.8 26.2 1.6 0.5 21.3 99 ± 1
Tis21-GFP −  NPCs 8.0 23.3 1.6 1.0 12.7
Tis21-GFP +  NPCs 2.4 21.7 1.6 0.6 17.1
AP and BP cell-cycle parameters were calculated from the data of Figures 2e, f and 4e and from the percentage of NPCs in m-phase. Average values for Tis21-GFP −  and Tis21-GFP +  NPCs were calcu-
lated taking into account the relative proportions of NPC populations in VZ + SVZ (see Supplementary Fig. S2). TC, total cell cycle; TS, S-phase; TG2, G2-phase; Tm, m-phase; TG1, G1-phase.ARTICLE
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We also observed an increase in the mRNA level of Cdk2ap1 
(ref. 50), an inhibitor of G1/S transition, in Tis21-GFP +  NPCs, 
consistent with the 1.3-fold increase in G1-phase duration (from 
12.7  to  17.1 h,  Table  1)  in  Tis21-GFP +   compared  with  Tis21-
GFP −  NPCs. However, mRNA levels of genes promoting G1/S 
transition, such as Cdk4 (ref. 51), were also upregulated. These 
functionally opposite changes in mRNA levels may reflect the fact 
that NPCs in S-phase had been isolated and subjected to micro-
array analysis.
The reduction in S-phase duration in Tis21-GFP +  compared 
with Tis21-GFP −  NPCs may also involve changes in gene expres-
sion that would affect the state of chromatin52,53. Indeed, we observed 
numerous such changes in mRNA levels, including genes involved 
in histone modification and DNA methylation. We also identified a 
number of genes implicated in NPC lineage progression, the mRNA 
levels of which were up- or down-regulated in Tis21-GFP +  com-
pared with Tis21-GFP −  NPCs (Table 2, Supplementary Note S4). 
Moreover, gene ontology (GO) term analysis (Supplementary Table 
S1, Supplementary Note S5) revealed that, remarkably, the down-
regulation of extracellular interactions is a major change that occurs 
in the transition from NPCs in S-phase destined to undergo pro-
liferative divisions (Tis21-GFP − ) to NPCs in S-phase destined to 
undergo differentiative divisions (Tis21-GFP + ).
Discussion
Using cumulative �dU labelling and defining the various classes 
of NPCs using molecular markers rather than the location of their 
nuclei in histologically defined zones, our study provides the first 
detailed breakdown of cell-cycle parameters for the various classes 
of NPCs. The first key observation is that BPs have a substantially 
longer G1-phase than do APs. This may reflect, for example, that 
BPs delaminate from the apical adherens junction belt, translocate 
their nuclei over a greater distance in the basal direction (typi-
cally to the SVZ) than APs do in G1, and retract their apical and 
basal processes5,7,9. In addition, consistent with the cell-cycle length 
hypothesis16,18, this G1 lengthening may causally contribute to the 
more differentiated state of BPs compared with APs, and, perhaps, 
promote BP fate.
Three  implications  of  our  data  are  addressed  in  the  Supple-
mentary Discussion: First, there is a need to reinterpret the previ-
ous observation14 that Tis21-GFP +  NPCs in the VZ have a longer 
G1 than do Tis21-GFP −  NPCs; second, the present finding of an 
equally long G2-phase in Tis21-GFP +  APs and Tis21-GFP +  BPs 
(Fig. 4e, Table 1) is in contrast to a previous conclusion14 that Tis21-
GFP +  BPs have a longer G2-phase than do Tis21-GFP +  APs; third, 
the determination of TC of Tis21-GFP +  BPs is valid.
The second key observation is that self-expanding NPCs have on 
an average a 3.3-fold (range 2.3- to 4.6-fold) longer S-phase than 
NPCs committed to the neurogenic lineage. In fact, the key differ-
ence in cell-cycle parameters between proliferating and neurogenic 
NPCs is in S-phase duration, observed with two independent exper-
imental  approaches,  whereas  the  other  cell-cycle  phases  remain 
constant for proliferating versus neurogenic APs, and for proliferat-
ing versus neurogenic BPs. This finding raises the possibility that 
S-phase duration is a key factor in the maintenance of proliferative 
capacity of NPCs. �vents in S-phase include DNA replication and 
repair coupled with cell-cycle checkpoints54,55. It has been reported 
that removal of Brca1, a gene associated with DNA repair, causes 
massive apoptosis in early but not late NPCs56, suggesting a stronger 
requirement for the DNA repair system in proliferative compared 
with neurogenic NPCs. One may speculate that proliferative, more 
unrestricted NPCs (in terms of lineage) have a stronger requirement 
for DNA replication fidelity and repair, as errors would be inherited 
to many more progeny than errors in NPCs already restricted to 
differentiation55,57.
Our data towards mechanistic insight into the change in S-phase 
duration are consistent with these considerations. First, determina-
tion of the rate of �dU incorporation revealed only an ≈20% increase 
in Tis21-GFP +  compared with Tis21-GFP −  NPCs (Fig. 5), indicating   
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Figure 3 | Identification of S-phase NPC nuclei by PCNA immunostaining. 
(a, b, c, d) Pax6 (magenta) or Tbr2 (magenta), PCNA (blue) and DAPI 
staining (c, d, white). Individual nuclei indicated by arrowheads in (a) and 
(b) are shown at higher magnification in (c) and (d), respectively; white 
arrowheads, S-phase nuclei showing punctate PCNA immunoreactivity; 
yellow arrowheads, G1- or G2-phase nuclei showing homogeneous PCNA 
immunoreactivity. All Pax6 +  nuclei (a) and all Tbr2 +  nuclei (b) that 
show punctate PCNA immunoreactivity are indicated by white dots in the 
respective right panel. Scale bars, 50 µm (a, b) and 10 µm (c, d).  
(e) Percentage of AP and BP nuclei that are in S-phase as revealed by 
PCNA immunostaining. Data show the percentage value of (BP) total 
Tbr2 +  nuclei in VZ + SVZ showing punctate PCNA immunoreactivity, 
corrected for the contribution of neurons, and of (AP) total Pax6 +  nuclei 
in VZ + SVZ showing punctate PCNA immunoreactivity, corrected for the 
contribution of BPs, and are the mean of four 225-µm-wide fields, each 
from a different brain and litter; error bars indicate s.d.; **P < 0.01.  
(a–e) Images in (a–d) and data in (e) are from embryos subjected to 
cumulative EdU labelling for 5 and 3–9 h, respectively.ARTICLE     
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that DNA replication proceeded only a little more slowly in the lat-
ter cells and implying that their substantially longer S-phase was 
not due to a correspondingly lower rate of DNA synthesis. Second, 
in line with their 1.6-fold shorter S-phase (Table 1), there was a 1.2-
fold increase in PCNA immunoreactivity in BPs compared with 
APs, which was observed at late, but not early, S-phase, consistent 
with the activity of the DNA replication machinery remaining at a 
higher level in late S-phase in BPs compared with APs (Fig. 6).
Third,  a  genome-wide  screen  for  changes  in  mRNA  levels 
between Tis21-GFP −  and Tis21-GFP +  NPCs in S-phase revealed 
several genes with key roles in cell-cycle regulation, DNA replication 
and repair and chromatin remodelling, the alterations in expression 
level of which provided possible mechanistic explanations for the 
difference in S-phase duration and its significance (Table 2). Thus, 
we observed for S-phase Tis21-GFP +  compared with Tis21-GFP −   
NPCs  an  upregulation  of  genes  implicated  in  increasing,  and  a 
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Figure 4 | Time course of appearance of EdU label in proliferative and neurogenic mitotic APs and BPs. (a–d) Phosphohistone H3 (PH3, blue), Tis21-
GFP (green), DAPI (white) and EdU (magenta) staining after cumulative EdU labelling for 1 h (a, c) and 3 h (b, d). Examples of cells in mitosis, as identified 
by positive PH3 immunostaining (PH3 + ) plus mitotic appearance on DAPI staining (DAPI-m), are indicated by arrowheads in (a) and (b) and are shown 
at higher magnification in (c) and (d), respectively; red arrowheads, DAPI-m/PH3 + /Tis21-GFP − /EdU −  cell (BP); green arrowheads, DAPI-m/PH3 + /
Tis21-GFP + /EdU −  cell (BP); blue arrowheads, DAPI-m/PH3 + /Tis21-GFP − /EdU −  cell (AP); purple arrowheads, DAPI-m/PH3 + /Tis21-GFP + /EdU −  cell 
(AP); red arrows, DAPI-m/PH3 + /Tis21-GFP − /EdU +  cell (BP); green arrows, DAPI-m/PH3 + /Tis21-GFP + /EdU +  cell (BP); blue arrows, DAPI-m/PH3 + /
Tis21-GFP − /EdU +  cell (AP); purple arrows, DAPI-m/PH3 + /Tis21-GFP + /EdU +  cell (AP). VZ and SVZ are indicated on the left. Scale bars, 50 µm (a, 
b) and 10 µm (c, d). (e) Proportion of EdU-labelled mitotic cells (mitotic EdU labelling index) after cumulative EdU labelling for the indicated times. The 
mitotic EdU labelling index was separately determined for proliferative APs (apical Tis21-GFP −  mitoses, blue diamonds), BP-genic/neurogenic APs (apical 
Tis21-GFP +  mitoses, purple squares), proliferative BPs (basal Tis21-GFP −  mitoses, red triangles) and neurogenic BPs (basal Tis21-GFP +  mitoses, green 
crosses). Data are the mean of three (except 2 h: where the mean is of two fields) 450-µm wide fields (sum of two 225-µm fields), each from a different 
brain and litter; error bars indicate s.e.m. or the range of the two individual values. (f) Diagram showing the duration of the cell-cycle phases in each NPC 
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downregulation of genes implicated in decreasing, S-phase dura-
tion; notably, the former included genes involved in the regulation 
of S-phase DNA checkpoints. Together, our data are consistent with 
the concept that the longer S-phase in Tis21-GFP −  compared with 
Tis21-GFP +  NPCs reflects, for the most part, an increased time 
investment into the quality control of replicated DNA.
It  has  previously  been  concluded12  that  S-phase  duration  in 
NPCs  during  cortical  neurogenesis  remains  relatively  constant. 
Our present finding that S-phase duration is dramatically differ-
ent  between  proliferating  and  neurogenic  NPCs  has  significant 
implications  for  studies  in  which  conclusions  about  the  extent 
of NPC proliferation are drawn from experiments using a sin-
gle administration of thymidine analogues, notably BrdU. Thus, 
a lower proportion of BrdU-labelled cells observed after a single 
administration may not necessarily be indicative of a lower rate of 
cell proliferation, as commonly assumed, but may actually reflect a 
higher rate because of a reduction in S-phase duration. The present 
study delineates experimental approaches suitable to avoid such 
ambiguities.
On a more general note, our study shows that cell-cycle regula-
tion of NPCs, a key aspect of cortical development16,17, is more com-
plex than previously assumed, involving major alterations not only 
in G1-phase but also in S-phase duration. The length of these cell-
cycle phases seems to be differentially linked to NPC proliferation 
versus differentiation, with G1-phase lengthening being associated 
with the transition to a more differentiated NPC type, and mainte-
nance of a long S-phase with NPC expansion.
Methods
Animals. Unless indicated otherwise, all mouse embryos used were �14.5 hetero-
zygous Tis21-GFP knock-in mice6 (C57BL/6 background), obtained by overnight 
mating of homozygous Tis21-GFP males with wild-type C57BL/6 females. Noon of 
the day on which the vaginal plug was observed was defined as embryonic day (�) 
0.5. All animal studies were conducted in accordance with German animal welfare 
legislation and in strict pathogen-free conditions in the animal facility of the Max  
Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. 
Protocols were approved by the Institutional Animal Welfare Officer (Tierschutz-
beauftragter), and necessary licenses were obtained from the regional �thical Com-
mission for Animal �xperimentation of Dresden, Germany (Tierversuchskommis-
sion, Landesdirektion Dresden).
EdU labelling. Cumulative �dU labelling was carried out by intraperitoneal injec-
tions, repeated at 3-h intervals up to 27 h, of 100 µl of 1 mg ml − 1 �dU (Invitrogen) 
in PBS into pregnant mice (27–32 g) carrying �14.5 embryos, corresponding to 
≈3.3 mg kg − 1 of pregnant mouse. Mice were killed at the time points indicated in 
figures and legends, and the embryo-containing uteri were transferred to ice-cold 
PBS to stop further incorporation of �dU.
In the case of comparison of cumulative BrdU and cumulative �dU labelling, 
100–120 µl of 10 mg ml − 1 BrdU (Sigma) in PBS, corresponding to 33–40 mg kg − 1  
of pregnant mouse, was coinjected with �dU, administered as above.
For FACS analysis, pregnant mice carrying �14.5 embryos were killed 30 min 
after a single �dU injection as above, and the embryo-containing uteri were trans-
ferred to ice-cold Tyrode’s solution to stop further incorporation of �dU.
Immunofluorescence and EdU staining. Immunofluorescence and �dU stain-
ing were performed on 10-µm transverse cryosections of dorsal telencephalon 
prepared from paraformaldehyde-fixed heads of �14.5 embryos, subjected to 
cumulative �dU labelling as indicated. For details, see Supplementary Methods. 
Unless indicated otherwise, images are 1.2-µm optical sections.
Analysis of cell-cycle parameters. For each of the NPC populations analysed 
(total APs, Tbr2 − /Pax6 + ; total BPs, Tbr1 − /Tbr2 + ; proliferative APs, Tbr2 − /
Pax6 + /Tis21-GFP − ; neurogenic APs, Tbr2 − /Pax6 + /Tis21-GFP + ; proliferative 
BPs, Tbr1 − /Tbr2 + /Tis21-GFP − ; neurogenic BPs, Tbr1 − /Tbr2 + /Tis21-GFP + ), 
the proportional values of �dU-positive nuclei obtained after the various times of 
cumulative labelling (�dU labelling index) were used to determine the following 
cell-cycle parameters, using the �xcel sheet provided by Dr R. Nowakowski24:  
the growth fraction, the proportion of total cell cycle covered by S-phase, TC–TS,  
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Figure 5 | Quantification of DNA synthesis rate by EdU incorporation in Tis21-GFP −  and Tis21-GFP +  NPCs. Following a 30-min EdU pulse labelling 
(two litters), cortical cells were dissociated, analysed by flow cytometry and sorted for Tis21-GFP fluorescence. Tis21-GFP −  and Tis21-GFP +  cells were 
then separately analysed for DNA content and EdU incorporation in another round of flow cytometry, as shown in the panels. (a, b) Granularity (side 
scatter, SSC; AU, arbitrary units) versus EdU fluorescence of single Tis21-GFP −  (a, 8,053 cells) and Tis21-GFP +  (b, 8,029 cells) cells. Dashed lines, 
overtly EdU-incorporating cells quantified in (c). Plots show one of the two litters analysed. (c) mean EdU fluorescence of the overtly EdU-incorporating 
single Tis21-GFP −  (grey column) and Tis21-GFP +  (green column) cells. For each litter, the mean EdU fluorescence of Tis21-GFP −  cells was arbitrarily 
set to 100, and the mean EdU fluorescence of Tis21-GFP +  cells was expressed relative to this. Data are the mean of two litters, dots indicate the two 
individual values. (d, e) Cell number versus DNA content of the single Tis21-GFP −  (d) and Tis21-GFP +  (e) cells shown in (a) and (b), respectively. 
Boxes indicate the sub-populations of cells in G0/G1, early S, late S and G2 + m phases, as defined by DNA content; cells in early and late S-phases 
were analysed for SSC versus EdU fluorescence in (g–j). (f) mean EdU fluorescence of the overtly EdU-incorporating single Tis21-GFP −  (grey columns) 
and Tis21-GFP +  (green columns) cells in early (g, i) and late (h, j) S-phase, as defined by DNA content (d, e) and after analysis of SSC versus EdU 
fluorescence (g–j). Quantification as in (c). (g–j) Granularity (SSC) versus EdU fluorescence of single Tis21-GFP −  (g, h) and Tis21-GFP +  (i, j) cells in early 
(g, i) and late (h, j) S phase shown in (d) and (e), respectively. Dashed lines, overtly EdU-incorporating cells quantified in (f). Plots show one of the two 
litters analysed. AU, arbitrary units.ARTICLE     
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TC and TS. The �dU labelling index curves were plotted using the Nowakowski 
�xcel sheet.
For estimating TG2, we first defined NPCs as being in a mitotic state if this was 
revealed by both PH3 immunofluorescence and DAPI staining. Mitotic figures 
within three nuclear diameters from the ventricular surface were considered 
mitotic APs; mitotic figures in the basal half of the VZ and in the SVZ were consid-
ered mitotic BPs. The time required for half-maximal appearance of �dU label in 
the various mitotic AP and BP populations was taken to indicate the average TG2. 
TM was calculated after determining the proportion of APs and BPs that were in 
mitosis, as identified by PH3 immunofluorescence and/or DAPI staining, taking 
into account the total cell-cycle length as determined by cumulative �dU label-
ling. Numbers of mitotic NPCs/total NPCs were as follows: total APs 372/7,832, 
Tis21-GFP −  APs 234/4,677, Tis21-GFP +  APs 138/3,155, total BPs 130/6,803, 
Tis21-GFP −  BPs 19/1,037, Tis21-GFP +  BPs 111/5,766; data are from 16 (mitotic 
APs and BPs), 17 (total APs) and 18 (total BPs) 225-µm-wide fields. The TC, TS, TG2 
and TM values were then used to calculate TG1 of the respective NPC population.
Determination of the percentage of S-phase nuclei by PCNA immunostaining. 
The antigen retrieval protocol necessary to obtain high-resolution PCNA im-
munostaining such as that shown in Figure 3c,d was not compatible with detecting 
Tis21-GFP by immunofluorescence, and did not yield high-quality PCNA images 
when combined with the present transcription factor double immunofluores-
cence protocol as used in Figure 1a,f, but allowed only single transcription factor 
immunofluorescence. We therefore used the following approach to quantify the 
proportion of APs and BPs in S-phase using the pattern of PCNA immunostaining. 
We first determined the percentage of total Pax6 +  (Fig. 3a) and total Tbr2 +  (Fig. 
3b) nuclei that were in S-phase. The percentage value for the Tbr2 +  S-phase nuclei 
obtained (11 ± 3%, n = 4, Fig. 3b) was then corrected for the contribution of neu-
rons (22 ± 1%, see Fig. 1g, VZ + SVZ, blue–red portion of the column), assumed to 
have no S-phase, to yield the percentage of BPs in S-phase (14 ± 4%, n = 4, Fig. 3e). 
Next, the latter value was used to correct the percentage value obtained for Pax6 +  
S-phase nuclei (23 ± 2%, n = 4, Fig. 3a) for the contribution of BPs (37 ± 2%, see Fig. 
1b, VZ + SVZ, blue–red portion of column) in S-phase, to obtain the percentage of 
APs in S-phase (30 ± 4%, n = 4, Fig. 3e).
Quantification of PCNA immunofluorescence of S-phase cells. PCNA im-
munofluorescence in Tbr2 −  and Tbr2 +  S-phase nuclei was quantified using the 
previously described ImageJ macro58, which allows for an unbiased, fluorescence 
intensity-based definition of nuclear area. For each nucleus, the average PCNA  
immunofluorescence was the sum of the values of each pixel divided by the 
number of pixels of that nucleus, with subtraction of a background value (de-
termined in the extracellular area). The macro also yielded the s.d. of the PCNA 
immunofluorescence signal between the pixels of a given nucleus.
Flow cytometry and FACS. Dorsal telencephalon (cerebral cortex) was dissected 
from �14.5 Tis21-GFP knock-in embryos in ice-cold Tyrode’s solution. Dissected 
tissue from three embryos (one litter) was minced using a pair of small forceps and 
incubated for 20 min at 37 °C in 700 µl of a 1:1 mixture of DM�M and Ham’s F-12 
(Invitrogen) containing 0.13% (w/v) DPCC-treated trypsin (Sigma, T1005), 0.067% 
(w/v) hyaluronidase (Sigma, H3884) and 0.02% (w/v) kynurenic acid (Sigma, 
K3375), followed by addition of 0.07% (w/v) soybean trypsin inhibitor (Sigma, 
T6522) in 700 µl of DM�M/Ham’s F-12. Tissue pieces and cells were collected 
by centrifugation at 600 g for 5 min and resuspended in 700 µl of DM�M/Ham’s 
F-12 containing 0.07% (w/v) trypsin inhibitor. The cells were dissociated by gentle 
trituration (10–20 up-and-down passages using a P-1000 tip), collected by centrifu-
gation at 600 g for 5 min and resuspended in 500 µl of DM�M/Ham’s F-12. The 
cell suspension was then passed through a filter (20-µm pore size, BD Bioscience) 
including a 500-µl rinse with DM�M/Ham’s F-12 to obtain ≈1 ml of a suspension 
enriched in single cells (≈6 × 105).
For the determination of �dU incorporation into Tis21-GFP −  and Tis21-
GFP +  NPCs, an aliquot of the cell suspension containing ≈104 cells was first 
analysed by flow cytometry using a FACSAria II cell sorter (BD Bioscience, run 
in PBS) and FACSDiva software to determine the range of Tis21-GFP fluores-
cence. For comparison, cells from �14.5 wild-type embryos not subjected to �dU 
labelling were analysed (see Supplementary Fig. S5a). Cells with a fluorescence 
value  > 1.05 × 103 U were defined as Tis21-GFP +  and cells with a fluorescence 
value  < 8 × 102 U (AU, arbitrary units) were defined as Tis21-GFP −  (see Sup-
plementary Fig. S5b). Single cells (as defined by particle size, see Supplementary 
Fig. S5c) were then sorted at room temperature to obtain ≈2 × 105 Tis21-GFP −  and 
Tis21-GFP +  cells each. Subsequent flow cytometry of an aliquot of the sorted cell 
suspensions revealed that Tis21-GFP −  cells did not contain detectable numbers 
of cells with a fluorescence value  > 1 × 103 U, and the contribution of cells with a 
fluorescence value  > 1 × 103 U (AU) to the Tis21-GFP +  cells was 99.5 ± 2%. Sorted 
Tis21-GFP −  and Tis21-GFP +  cells were separately processed using the Click-iT 
�dU Flow Cytometry Assay Kit with Alexa Fluor 647 for �dU detection, in com-
bination with Click-iT �dU CellCycle 405-blue for DNA content determination 
(Invitrogen), according to the manufacturer’s instructions, followed by another 
round of flow cytometry of the fixed and stained cells to define the populations of 
overtly �dU-incorporating cells and of cells in early or late S-phase, and to measure 
the amount of �dU incorporation into these cells.
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Figure 6 | Quantification of PCNA immunofluorescence in Tbr2 −  and 
Tbr2 +  NPCs in early versus late S-phase. (a, b) Representative examples 
of PCNA immunofluorescence (white, middle panels, z-stack of five 0.95-
µm optical sections from the centre of the nucleus) of Tbr2 −  (left panels) 
and Tbr2 +  (right panels) NPCs. Nuclei showing relatively homogeneous 
PCNA immunoreactivity with a predominantly small punctate pattern were 
considered as early S-phase (a), nuclei showing a more heterogeneous 
PCNA immunoreactivity with a few strong clusters were considered as 
late S-phase (b). Intensity of PCNA immunofluorescence is shown in 
pseudocolour in the lower panels (blue, low values (0 = lowest); red, high 
values (255 = highest). Scale bars, 10 µm. (c–f) Quantification of PCNA 
immunofluorescence of Tbr2 −  and Tbr2 +  NPCs in early and late S-phase 
as defined in (a) and (b), respectively. Data are from the same cryosection 
per embryo and are from three embryos, each from a different litter. 
Numbers of nuclei analysed for embryos 1, 2, 3, were Tbr2 −  early S (13, 
14, 10), Tbr2 +  early S (13, 12, 7), Tbr2 −  late S (8, 9, 5), Tbr2 +  late S (8, 
9, 4). (c, d) Average PCNA immunofluorescence (AU, arbitrary units) of 
individual Tbr2 −  (circles) and Tbr2 +  (triangles) nuclei in early (c) and 
late (d) S-phase, plotted in order of increasing values, with the highest 
Tbr2 −  and Tbr2 +  value arbitrarily set to 1. Red, green, blue symbols 
indicate embryos 1, 2, 3, respectively. Data distribution of Tbr2 −  versus 
Tbr2 +  nuclei in late S-phase (d), Kolmogorov–Smirnov P-value = 0.002. 
(e) Average PCNA immunofluorescence per nucleus of Tbr2 −  (black) and 
Tbr2 +  (magenta) nuclei in early (left) and late (right) S-phase. Data are 
the mean of the values from the three embryos shown in (c) and (d); error 
bars, s.d.; *P = 0.028. (f) s.d. of PCNA immunofluorescence between the 
pixels of a given nucleus. For each embryo, the mean s.d. of Tbr2 −  nuclei 
(black) in early (left) and late (right) S-phase was arbitrarily set to 1, and 
the mean s.d. of Tbr2 +  nuclei (magenta) was expressed relative to this. 
Data are the mean of the three embryos; error bars, s.d.; ***P = 0.001.ARTICLE
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Table 2 | mRNAs differentially expressed in FACS-isolated Tis21-GFP +  versus Tis21-GFP −  S-phase NPCs of E14.5 mouse neocortex.
Gene category Gene (abbr.) Gene (full name) Function FC  P-value
Validation Eomes Eomesodermin homolog (Xenopus laevis), Tbr2 Proneural gene, BP marker  + 8.7 0.015
Neurog2 Neurogenin 2 Proneural gene  + 4.4 0.014
Insm1 Insulinoma-associated 1 Panneurogenic, BP-genic gene  + 4.3 0.031
Fabp7 Fatty acid-binding protein 7 Neural stem cell maintenance  − 2.9 0.014
Nes Nestin Intermediate filament protein, AP marker  − 2.3 0.026
Cell-cycle regulation Cdkn1c Cyclin-dependent kinase inhibitor 1C (p57) Antiproliferative gene  + 3.0 0.022
Ccng2 Cyclin G2 mid/late S-phase cyclin  + 2.4 0.007
Rb1 Retinoblastoma 1 G1/S transition regulator  + 2.4 0.013
Cdk2ap1 Cdk2 (cyclin-dependent kinase 2)-associated 
protein 1
Cdk2 inhibitor  + 1.7 0.011
Cdc25a Cell division cycle 25 homolog A 
(Schizosaccharomyces pombe)
Activator of S-phase progression, regulator  
of DNA checkpoints
 + 1.6 0.027
Cdk4 Cyclin-dependent kinase 4 G1/S transition  + 1.5 0.012
Erf Ets2 repressor factor Repressor of c-myc and cdc2  − 3.0 0.039
Cdkl2 Cyclin-dependent kinase-like 2 Cyclin-dependent kinase  − 2.5 0.042
Fbxw7 F-box and WD-40 domain protein 7 Subunit of ubiquitin ligase complex promoting 
degradation of cell cycle-positive regulators
 − 1.9 0.019
DNA replication and 
repair
E2f1 E2F transcription factor 1 Positive regulator for S-phase progression  + 2.2 0.016
Fen1 Flap structure-specific endonuclease 1 Positive regulator of Okazaki fragment 
maturation and base excision repair
 + 2.0 0.039
Fancf Fanconi anemia, complementation group F Positive regulator of translesion synthesis  + 1.7 0.031
Rnaseh2b Ribonuclease H2, subunit B Positive regulator of Okazaki fragment  + 1.5 0.016
Top2a Topoisomerase (DNA) II alpha Regulator of DNA checkpoints, relaxing 
supercoiled DNA
 + 1.5 0.046
Tdg Thymine DNA glycosylase Initiator of base excision repair  + 1.3 0.041
Chd1l Chromodomain helicase DNA-binding 
protein 1-like
Positive regulator of chromatin relaxation  
for DNA repair
 − 2.2 0.031
Parp16 Poly(ADP-ribose) polymerase family, 
member 16
Positive regulator of DNA repair  − 1.9 0.042
Chromatin 
remodeling
Gadd45g Growth arrest and DNA-damage-inducible 
45 gamma
DNA demethylase  + 4.1 0.032
Cbx2 Chromobox homolog 2 (Drosophila Pc class) Polycomb repressive complex subunit  + 1.9 0.007
Phc2 Polyhomeotic-like 2 (Drosophila) Polycomb repressive complex subunit  + 1.6 0.020
Kdm1a Lysine (K)-specific demethylase 1A Histone modifier  + 1.6 0.042
Hdac2 Histone deacetylase 2 Histone modifier  + 1.5 0.030
H3f3b H3 histone, family 3B Chromatin component  + 1.5 0.031
Kdm2b Lysine (K)-specific demethylase 2B Histone modifier  + 1.5 0.046
Brd3 Bromodomain containing 3 Histone modifier  + 1.4 0.026
Bmi1 Bmi1 polycomb ring finger oncogene Polycomb repressive complex subunit  + 1.3 0.033
Sin3a Transcriptional regulator, SIN3A (yeast) Regulator of histone modification  + 1.3 0.040
Hils1 Histone H1-like protein in spermatids 1 Chromatin component  − 3.6 0.010
Hmga2 High-mobility group AT-hook 2 Chromatin component  − 3.4 0.037
Pcgf5 Polycomb group ring finger 5 Polycomb repressive complex subunit  − 2.1 0.049
Mbd2 methyl-CpG-binding domain protein 2 Histone modifier  − 1.9 0.024
Neurogenesis Neurod1 Neurogenic differentiation 1 Proneural gene  + 5.5 0.017
Insc Inscuteable homolog (Drosophila) Regulator of mitotic spindle orientation  + 5.3 0.014
Dll3 Delta-like 3 (Drosophila) Notch ligand  + 4.7 0.015
Insm2 Insulinoma-associated 2 Presumptive panneurogenic, BP-genic gene  + 4.2 0.030
Hes6 Hairy and enhancer of split 6 (Drosophila) Positive regulator of neurogensis  + 3.3 0.012
Numbl Numb-like Notch inhibitor  + 2.1 0.013
Ascl1 Achaete-scute complex homolog 1 (Drosophila) Positive regulator of neurogensis  + 2.1 0.028
Notch3 Notch gene homolog 3 (Drosophila) Neural stem cell maintenance  − 4.1 0.012
Wnt7a Wingless-related mmTV integration site 7A Neural stem cell maintenance  − 3.8 0.025
Sox8 SRY-box containing gene 8 Oligodendrocyte specification  − 3.8 0.027
Notch2 Notch gene homolog 2 (Drosophila) Neural stem cell maintenance  − 3.6 0.019
Fgfr2 Fibroblast growth factor receptor 2 Neural stem cell maintenance  − 2.6 0.016
Dtx4 Deltex 4 homolog (Drosophila) Positive regulator of Notch  − 2.6 0.049
Sox1 SRY-box containing gene 1 Stem cell maintenance  − 2.2 0.031
Fgf18 Fibroblast growth factor 18 Neural stem cell maintenance  − 2.0 0.049
Tle1 Transducin-like enhancer of split 1 Neural stem cell maintenance  − 1.9 0.033
Jag1 Jagged 1 Notch ligand  − 1.6 0.015
Abbreviation: FC, fold change.
Selected mRNAs whose level in Tis21-GFP +  compared to Tis21-GFP −  S-phase NPCs were significantly (P < 0.05) at least 1.2-fold up- ( + , orange background) or down- ( − ) regulated are listed.ARTICLE     
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For microarray analysis, filtered cells obtained from the dorsal telencephalon of 
�14.5 Tis21-GFP knock-in embryos as above were incubated for 1 h at 37 °C with a 
vital DNA dye (2 µl of Vybrant DyeCycle Violet Stain, Invitrogen). Live cells were 
analysed by flow cytometry to identify the population in S-phase on the basis of 
the level of DNA fluorescence (see Supplementary Fig. S5d,e), and single live cells 
were then sorted to collect Tis21-GFP −  and Tis21-GFP +  NPCs in S-phase cells, 
using the above FACS settings, which yielded 1–4 × 104 cells each per FACS run. 
The sorted cell suspensions were centrifuged at 600 g for 5 min, the supernatant 
discarded and cell pellets frozen in liquid nitrogen and stored at  − 80 °C.
Microarray analysis. Cell pellets of Tis21-GFP −  and Tis21-GFP +  NPCs in 
S-phase were thawed in 102 µl of lysis buffer supplied with a total RNA isolation 
kit (NucleoSpin RNA XS, Macherey-Nagel). The cell lysate from one cell pellet 
was used consecutively to thaw the next cell pellet until a cell lysate corresponding 
to 1.5–2.0 × 105 cells was obtained. Total RNA was extracted using the Nucleo-
Spin RNA XS kit according to the manufacturer’s instructions. RNA from three 
independent experiments was used to perform One-Color Microarray-Based 
Gene �xpression Analysis according to the manufacturer’s instructions (Agilent 
Technologies). For each sample, 50 ng total RNA was used to prepare Cy3-labelled 
target cRNA with the Low Input Quick Amp Labeling Kit (Agilent Technologies). 
The target cRNAs were hybridized to SurePrint G3 Mouse G� 8 × 60K Microar-
rays (AMADID 028005, Agilent Technologies). Scanned images were analysed 
with Feature �xtraction software 10.7.1.1 (Agilent Technologies) using default 
parameters (protocol: G�1_107_Sep09, grid: 028005_D_F_20100617) to obtain 
background-corrected signal intensities. The data were further analysed with 
GeneSpring GX Software (Version 11.0, Agilent Technologies). After quantile 
normalization of the data and removal of unreliable signal intensities (filtering of 
data by expression: in three out of six experiments the signal intensity of a probe 
had to be above the 20th percentile to be retained in the data set), mRNAs were 
considered differentially expressed in Tis21-GFP +  versus Tis21-GFP −  cells if they 
had a corrected P-value  < 0.05 after an unpaired t-test and multiple testing correc-
tion (Benjamini Hochberg). 
GO term analysis of the differentially expressed mRNAs was performed with 
GeneSpring GX software, using a corrected P-value cutoff of  < 0.05 to define a GO 
term as being significantly increased or decreased in frequency as compared with 
the total population of mRNAs represented on the microarray.
Statistical analyses. P-values were determined using Student’s t-test (two-sample 
equal variance, two tails). When indicated, the Kolmogorov–Smirnov test was used 
instead. 
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